TET3 Inhibits Type I IFN Production Independent of DNA Demethylation

Cell Reports

Volumn 16, Issue 4, 2016, Pages 1096-1105

  Xue, Shengjie ^a   Liu, Chang ^a   Sun, Xiujie ^a   Li, Weiyun ^a   Zhang, Chi ^a   Zhou, Xin ^a   Lu, Yao ^a   Xiao, Jun ^a   Li, Chunyang ^a   Xu, Xiaoyan ^a   Sun, Bing ^a   Xu, Guoliang ^a   Wang, Hongyan ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; HISTONE DEACETYLASE 1; INTERFERON; MEMBRANE PROTEIN; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN TET3; TRANSCRIPTION FACTOR SIN3A; UNCLASSIFIED DRUG; DNA; DNA BINDING PROTEIN; GAMMA INTERFERON; IFNG PROTEIN, MOUSE; ONCOPROTEIN; REPRESSOR PROTEIN; SIN3A TRANSCRIPTION FACTOR; TET3 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CATALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMETHYLATION; ENZYME ACTIVITY; GENE; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IFNB1 GENE; IMMUNOCOMPETENT CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; VIRAL CLEARANCE; VIRUS INFECTION; ANIMAL; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; DEMETHYLATION; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEK293 CELLS; HISTONE DEACETYLASE 1; HUMANS; INTERFERON TYPE I; INTERFERON-BETA; INTERFERON-GAMMA; MICE; POLY I-C; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 84978893123     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.06.068     Document Type: Article

References (42)

1. Álvarez-Errico, D., Vento-Tormo, R., Sieweke, M., Ballestar, E., Epigenetic control of myeloid cell differentiation, identity and function. Nat. Rev. Immunol. 15 (2015), 7–17.
2. Branco, M.R., Ficz, G., Reik, W., Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat. Rev. Genet. 13 (2012), 7–13.
3. Carrero, J.A., Calderon, B., Unanue, E.R., Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 200 (2004), 535–540.
4. Cartron, P.F., Nadaradjane, A., Lepape, F., Lalier, L., Gardie, B., Vallette, F.M., Identification of TET1 partners that control its DNA-demethylating function. Genes Cancer 4 (2013), 235–241.
5. Cimmino, L., Dawlaty, M.M., Ndiaye-Lobry, D., Yap, Y.S., Bakogianni, S., Yu, Y., Bhattacharyya, S., Shaknovich, R., Geng, H., Lobry, C., et al. TET1 is a tumor suppressor of hematopoietic malignancy. Nat. Immunol. 16 (2015), 653–662.
6. Comi, G., Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta. Clin. Ther. 31 (2009), 1142–1157.
7. Du, M., Liu, J., Chen, X., Xie, Y., Yuan, C., Xiang, Y., Sun, B., Lan, K., Chen, M., James, S.J., et al. Casein kinase II controls TBK1/IRF3 activation in IFN response against viral infection. J. Immunol. 194 (2015), 4477–4488.
8. Figueroa, M.E., Abdel-Wahab, O., Lu, C., Ward, P.S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H.F., et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18 (2010), 553–567.
9. Ford, E., Thanos, D., The transcriptional code of human IFN-beta gene expression. Biochim. Biophys. Acta 1799 (2010), 328–336.
10. Gu, T.P., Guo, F., Yang, H., Wu, H.P., Xu, G.F., Liu, W., Xie, Z.G., Shi, L., He, X., Jin, S.G., et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477 (2011), 606–610.
11. He, Y.F., Li, B.Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333 (2011), 1303–1307.
12. Hoebe, K., Du, X., Georgel, P., Janssen, E., Tabeta, K., Kim, S.O., Goode, J., Lin, P., Mann, N., Mudd, S., et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424 (2003), 743–748.
13. Hou, J., Wang, P., Lin, L., Liu, X., Ma, F., An, H., Wang, Z., Cao, X., MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183 (2009), 2150–2158.
14. Hu, X., Zhang, L., Mao, S.Q., Li, Z., Chen, J., Zhang, R.R., Wu, H.P., Gao, J., Guo, F., Liu, W., et al. Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming. Cell Stem Cell 14 (2014), 512–522.
15. Hu, L., Lu, J., Cheng, J., Rao, Q., Li, Z., Hou, H., Lou, Z., Zhang, L., Li, W., Gong, W., et al. Structural insight into substrate preference for TET-mediated oxidation. Nature 527 (2015), 118–122.
16. Huber, K., Doyon, G., Plaks, J., Fyne, E., Mellors, J.W., Sluis-Cremer, N., Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells. J. Biol. Chem. 286 (2011), 22211–22218.
17. Ito, S., D'Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C., Zhang, Y., Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466 (2010), 1129–1133.
18. Johnstone, R.W., Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1 (2002), 287–299.
19. Li, K., Foy, E., Ferreon, J.C., Nakamura, M., Ferreon, A.C., Ikeda, M., Ray, S.C., Gale, M. Jr., Lemon, S.M., Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102 (2005), 2992–2997.
20. Li, C., Li, W., Xiao, J., Jiao, S., Teng, F., Xue, S., Zhang, C., Sheng, C., Leng, Q., Rudd, C.E., et al. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. EMBO Mol. Med. 7 (2015), 754–769.
21. Li, W., Xiao, J., Zhou, X., Xu, M., Hu, C., Xu, X., Lu, Y., Liu, C., Xue, S., Nie, L., et al. STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma. J. Clin. Invest. 125 (2015), 4239–4254.
22. Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M.E., Vasanthakumar, A., Patel, J., Zhao, X., et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20 (2011), 11–24.
23. Noseworthy, J.H., Lucchinetti, C., Rodriguez, M., Weinshenker, B.G., Multiple sclerosis. N. Engl. J. Med. 343 (2000), 938–952.
24. Nusinzon, I., Horvath, C.M., Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation. Mol. Cell. Biol. 26 (2006), 3106–3113.
25. Quivoron, C., Couronné, L., Della Valle, V., Lopez, C.K., Plo, I., Wagner-Ballon, O., Do Cruzeiro, M., Delhommeau, F., Arnulf, B., Stern, M.H., et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20 (2011), 25–38.
26. Richards, K.H., Macdonald, A., Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production. Microbes Infect. 13 (2011), 291–302.
27. Rönnblom, L., Alm, G.V., Eloranta, M.L., Type I interferon and lupus. Curr. Opin. Rheumatol. 21 (2009), 471–477.
28. Schübeler, D., Function and information content of DNA methylation. Nature 517 (2015), 321–326.
29. Shestakova, E., Bandu, M.T., Doly, J., Bonnefoy, E., Inhibition of histone deacetylation induces constitutive derepression of the beta interferon promoter and confers antiviral activity. J. Virol. 75 (2001), 3444–3452.
30. Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L., Rao, A., Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324 (2009), 930–935.
31. Tan, L., Shi, Y.G., Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 139 (2012), 1895–1902.
32. Teijaro, J.R., Ng, C., Lee, A.M., Sullivan, B.M., Sheehan, K.C., Welch, M., Schreiber, R.D., de la Torre, J.C., Oldstone, M.B., Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340 (2013), 207–211.
33. Trinchieri, G., Type I interferon: friend or foe?. J. Exp. Med. 207 (2010), 2053–2063.
34. West, A.C., Johnstone, R.W., New and emerging HDAC inhibitors for cancer treatment. J. Clin. Invest. 124 (2014), 30–39.
35. Williams, K., Christensen, J., Pedersen, M.T., Johansen, J.V., Cloos, P.A., Rappsilber, J., Helin, K., TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473 (2011), 343–348.
36. Wilson, E.B., Yamada, D.H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B.J., Karp, C.L., Brooks, D.G., Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340 (2013), 202–207.
37. Wu, S., He, L., Li, Y., Wang, T., Feng, L., Jiang, L., Zhang, P., Huang, X., miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6. J. Infect. 67 (2013), 329–341.
38. Yang, R., Qu, C., Zhou, Y., Konkel, J.E., Shi, S., Liu, Y., Chen, C., Liu, S., Liu, D., Chen, Y., et al. Hydrogen sulfide promotes Tet1- and Tet2-mediated Foxp3 demethylation to drive regulatory T cell differentiation and maintain immune homeostasis. Immunity 43 (2015), 251–263.
39. Zhang, S.Y., Jouanguy, E., Ugolini, S., Smahi, A., Elain, G., Romero, P., Segal, D., Sancho-Shimizu, V., Lorenzo, L., Puel, A., et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317 (2007), 1522–1527.
40. Zhang, Y., Lu, Y., Ma, L., Cao, X., Xiao, J., Chen, J., Jiao, S., Gao, Y., Liu, C., Duan, Z., et al. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signaling and protects against endotoxin shock. Immunity 40 (2014), 501–514.
41. Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525 (2015), 389–393.
42. Zhong, C., Yin, Q., Xie, Z., Bai, M., Dong, R., Tang, W., Xing, Y.H., Zhang, H., Yang, S., Chen, L.L., et al. CRISPR-Cas9-mediated genetic screening in mice with haploid embryonic stem cells carrying a guide RNA library. Cell Stem Cell 17 (2015), 221–232.